Open AccessDREADD Agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo
Author(s) -
K.J. Thompson,
E. Khajehali,
S.J. Bradley,
J.S. Navarrete,
X.P. Huang,
S. Slocum,
Jiarou Jin,
Jiaxin Liu,
Y. Xiong,
R.H.J. Olsen,
J.F. Diberto,
K.M. Boyt,
M.M. Pina,
D. Pati,
C. Molloy,
C. Bundgaard,
P.M. Sexton,
T.L. Kash,
M.J. Krashes,
A. Christopoulos,
B.L. Roth,
A.B. Tobin
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/g3y2-9z91
Subject(s) - agonist , in vivo , muscarinic agonist , muscarinic acetylcholine receptor , pharmacology , neuroscience , in vitro , chemistry , medicine , receptor , psychology , biology , biochemistry , microbiology and biotechnology